Algentics is a Canadian biotech innovation company that integrates AI, structural biology, and wet lab validation to advance precision medicine. We specialize in in silico treatment modelling, protein-ligand docking, and drug resistance prediction using cutting-edge tools like AlphaFold, Rosetta, and ProteinMPNN. Our mission is to help oncologists, biotech teams, and researchers deliver faster, more cost-effective, and personalized treatment decisions. We combine computational biology with experimental science to close the gap between prediction and clinical action—transforming how therapies are evaluated and delivered. Founded by PhDs in AI/ML and Immuno-Oncology, Algentics is committed to improving access, reducing treatment costs, and advancing real-world clinical impact through science and technology.
| Website | http://www.algentics.com |
| Employees | 2 (1 on RocketReach) |
| Founded | 2025 |
| Industry | Biotechnology Research |
Looking for a particular Algentics employee's phone or email?
Algentics Questions
Zeinab Dalloul is the Co-Founder and Onco-Immuno Specialist of Algentics.
1 people are employed at Algentics.
Algentics is based in Moncton, New Brunswick.
Top Algentics Employees
-
Zeinab Dalloul
Co-Founder and Onco-Immuno Specialist at Algentics
Vancouver, BC, CA2
